共 118 条
[1]
Assifi MM(2011)Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials Surgery 150 466-473
[2]
Lu X(2015)Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial Radiother Oncol 117 432-437
[3]
Eibl G(2016)Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: analysis of the on-trial cases for the SCALOP trial Radiother Oncol 120 212-216
[4]
Reber HA(2016)Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without Erlotinib: the LAP07 Randomized Clinical Trial JAMA 315 1844-1853
[5]
Li G(2007)Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies J Clin Oncol 25 326-331
[6]
Hines OJ(2015)Health-related quality of life in SCALOP, a randomized phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 93 810-818
[7]
Fokas E(2013)Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial Lancet Oncol 14 317-326
[8]
Clifford C(2014)A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites Cancer 120 302-311
[9]
Spezi E(2016)ARCII: a phase II trial of the HIV protease inhibitor nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer Radiother Oncol 119 306-311
[10]
Joseph G(undefined)undefined undefined undefined undefined-undefined